Screener
Rapport Therapeutics, Inc. RAPP Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For The Six Months Ended June 30, 2026 | For The Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss from operations | (60,806) | (29,496) | (85,021) | (56,604) |
| Other income: | ||||
| Interest income | 4,191 | 2,764 | 8,549 | 5,809 |
| Total other income | 4,191 | 2,764 | 8,549 | 5,809 |
| Net loss | $(56,615) | $(26,732) | $(76,472) | $(50,795) |
| Net loss per share attributable to common stockholders, basic and diluted | $(1.19) | $(0.75) | $(1.61) | $(1.44) |
| Weighted-average common shares outstanding, basic and diluted | 47,473,174 | 35,444,635 | 47,355,550 | 35,356,098 |
| Comprehensive loss: |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s other income (expense)?
- Rapport Therapeutics, Inc. (RAPP) reported other income (expense) of $4.19M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Rapport Therapeutics, Inc.'s other income (expense) increased by 51.6% year-over-year, from $2.76M to $4.19M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Rapport Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude